๐Ÿ›๏ธ Verified NIH Record โ€ข Updated 2025-10-15

Neuromodulation in Substance Use Disorders (NCT07010016)

๐Ÿ”ต Active, Not Recruiting Observational / Diagnostic โš™๏ธ Medical Device Protocol Sponsor: Manish Ranjan

๐Ÿฉบ Plain-English Summary (8th-Grade Level)

The primary objective of this study is to assess the safety and feasibility of FUS neuromodulation in participants with OUD and/or other SUDs.

Who can join: To join this study, participants generally need to meet the listed inclusion criteria (6 items) and avoid the listed exclusions (14 items).

Location: WVU Rockefeller Neuroscience Institute โ€” Morgantown, West Virginia

๐Ÿ“‹ "Do I Qualify?" โ€” 1-Minute Self Screener

Instant Checklist

Check every box below. If you can check all of them, you may meet the study's basic screening requirements (final eligibility is confirmed by the site team).

Usually NOT eligible if any of the following apply:

  • Exclusion Criteria:
  • Unable to undergo MR-imaging because of non-MR compatible implants or if candidates are uncomfortable in small spaces (have claustrophobia).
  • History of any clinically significant neurological disorder.
  • History of stroke or brain lesion with observable structural abnormalities in the targeted brain region.
  • Clinically significant MRI abnormality indicative of a neurological condition or abnormality that may jeopardize the participant's safety, study conduct, or confound the participant's diagnostic assessments.
  • An abnormal screening result that is considered clinically significant by a medically qualified research team member (i.e., laboratory tests, imaging findings).
  • More than 30% of the skull area traversed by the sonication pathway is covered by scars, scalp disorders (e.g., eczema), or atrophy of the scalp.
  • Past or present diagnosis of schizophrenia or psychotic disorder (assessed via SCID-
  • History of medically verified suicide attempt within the past year.
  • Meet the criteria for Cluster A or B Personality Disorders (assessed via SCID-5-PD).
  • Current substance use treatment mandated by court of law.
  • Subject who is currently participating in another clinical investigation with an active

๐Ÿ” Extracted verbatim from the official NIH eligibility criteria. Always confirm with the study coordinator.

๐Ÿ“ All Participating Trial Locations (1 Sites)

  • WVU Rockefeller Neuroscience Institute โ€” Morgantown, West Virginia

๐Ÿ’ฐ Cost, Insurance & Patient Rights

  • 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
  • Routine Patient Care: Under federal law (ACA ยง 2709) and many state statutes, routine care costs are covered during participation.
  • Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
๐Ÿ›๏ธ View Official NIH Record โ†—